Laboratoire Inserm UMR 1188 DéTROI, Saint-Pierre, La Réunion, France.
Laboratoire Inserm UMR 1188 DéTROI, Saint-Pierre, La Réunion, France; Faculté de Médecine, Université de La Réunion, Saint-Pierre, La Réunion, France.
J Lipid Res. 2023 Sep;64(9):100426. doi: 10.1016/j.jlr.2023.100426. Epub 2023 Aug 14.
In the past 20 years, PCSK9 has been shown to play a pivotal role in LDL cholesterol metabolism and cardiovascular health by inducing the lysosomal degradation of the LDL receptor. PCSK9 was discovered by the cloning of genes up-regulated after apoptosis induced by serum deprivation in primary cerebellar neurons, but despite its initial identification in the brain, the precise role of PCSK9 in the nervous system remains to be clearly established. The present article is a comprehensive review of studies published or in print before July 2023 that have investigated the expression pattern of PCSK9, its effects on lipid metabolism as well as its putative roles specifically in the central and peripheral nervous systems, with a special focus on cerebrovascular and neurodegenerative diseases.
在过去的 20 年中,PCSK9 通过诱导 LDL 受体的溶酶体降解,被证明在 LDL 胆固醇代谢和心血管健康中发挥关键作用。PCSK9 是通过克隆在原代小脑神经元因血清剥夺诱导的凋亡后上调的基因而发现的,但尽管它最初在大脑中被鉴定出来,但其在神经系统中的精确作用仍有待明确确定。本文是对 2023 年 7 月之前发表或印刷的研究 PCSK9 表达模式、对脂代谢的影响以及其在中枢和外周神经系统中的潜在作用的综合综述,特别关注脑血管病和神经退行性疾病。